409 ILLINOIS STREET, SAN FRANCISCO, CA
Unaudited Pro Forma Condensed Consolidated Financial Information
Completes Sale of China to AstraZeneca for Approximately $220 Million
Approval of Sale of China to AstraZeneca by the China State Administration for Market Regulation
Earnings Release
News, Material Contracts
End of Material Contract
Announces 1-for-25 Reverse Stock Split
Material Contracts, Changes in Board, Management or Compensation, Shareholder votes
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence